Crossmark

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity

Crossref DOI link: https://doi.org/10.1038/ni.3728

Published Online: 2017-04-17

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chung, Kyoung-Jin

Chatzigeorgiou, Antonios

Economopoulou, Matina

Garcia-Martin, Ruben

Alexaki, Vasileia I

Mitroulis, Ioannis

Nati, Marina

Gebler, Janine

Ziemssen, Tjalf

Goelz, Susan E

Phieler, Julia

Lim, Jong-Hyung

Karalis, Katia P

Papayannopoulou, Thalia

Blüher, Matthias

Hajishengallis, George https://orcid.org/0000-0001-7392-8852
Chavakis, Triantafyllos
License Information

Text and Data Mining valid from 2017-04-17
More Information

Article History

Received: 5 August 2016

Accepted: 20 March 2017

First Online: 17 April 2017

Competing interests

: S.E.G. is a former employee of ELAN Pharmaceuticals and Biogen Idec. The ELND002 inhibitor of α<sub>4</sub> integrin was produced by ELAN Pharmaceuticals and was provided by ELAN Pharmaceuticals and by Biogen Idec.